Document Detail

Characteristics of hypertension in Chinese and their relevance for the choice of antihypertensive drugs.
MedLine Citation:
PMID:  23280869     Owner:  NLM     Status:  In-Data-Review    
According to the 4th National Nutrition and Health Survey in 2002, the prevalence of hypertension in China was 18.8%. Despite that, the treatment rate among hypertensive patients was 82%, the control rate remained low in persons with hypertension (6%), because of the low awareness in general (30%) and the low control rate among treated hypertensive patients (25%). One of the major reasons for the increasing prevalence of hypertension is unbalance of dietary sodium and potassium intakes. In the International Study of Macro/Micro-nutrients and Blood Pressure (INTERMAP), Chinese, compared with American, British, and Japanese populations, had highest dietary sodium intakes and lowest potassium intakes, leading to a two to three times higher sodium/potassium ratio. High dietary sodium intakes may change the circadian rhythm of 24 h blood pressure, which is characterized by a higher night-time blood pressure. Indeed, the prevalence of isolated night-time hypertension, defined as a night-time blood pressure of at least 120 mmHg systolic or 70 mmHg diastolic and a daytime systolic/diastolic blood pressure less than 135/85 mmHg, was higher in Chinese than in Europeans. The complications of hypertension are also different across ethnicities, being mainly stroke instead of myocardial infarction in Chinese. Blood pressure lowering provides more protection against stroke than myocardial infarction, and calcium channel blockers provide more protection against stroke than other classes of antihypertensive drugs. Current Chinese hypertension guidelines recommend calcium channel blockers as the first of the five classes of antihypertensive drugs for stage 1 and low-risk hypertension.
Ji-Guang Wang; Yan Li
Related Documents :
24892879 - Invasive validation of the complior analyse in the assessment of central artery pressur...
23706609 - Incidence of cerebrovascular lesions in pure autonomic failure.
10972219 - Intragraft expression of transforming growth factor-beta 1 by a novel quantitative reve...
23715049 - Impact of late calcineurin inhibitor withdrawal on ambulatory blood pressure and caroti...
24893089 - Resistant hypertension: a review of diagnosis and management.
17919819 - Dental and skeletal changes during pressure garment use in facial burns: a systematic r...
2900129 - Experimental studies on the neurocardiovascular effects of urapidil.
10226219 - Benefits of ambulatory blood pressure monitoring in the design of antihypertensive drug...
11720109 - What do international guidelines say about therapy?
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Diabetes/metabolism research and reviews     Volume:  28 Suppl 2     ISSN:  1520-7560     ISO Abbreviation:  Diabetes Metab. Res. Rev.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2013-01-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883450     Medline TA:  Diabetes Metab Res Rev     Country:  England    
Other Details:
Languages:  eng     Pagination:  67-72     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 John Wiley & Sons, Ltd.
Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  What should be the antihypertensive drug of choice in diabetic patients and should we avoid drugs th...
Next Document:  Continuous glucose monitoring: current clinical use.